The latest news & stories from the Providence Research Network
-
Angiosarcoma on the rise: new study reveals implications for cancer care and research
The largest study of angiosarcoma published to date, co-authored at Providence, describes the incidence and presentation patterns of angiosarcoma, a rare but potentially deadly cancer.
-
Improving access to cutting-edge research and clinical trials
Two stories of how, together with our industry partners and patients, Providence is working to make the latest trials available to more people who could benefit from them.
-
Cutting-edge Research to Create Better Solutions for Prostate Cancer
Providence St. Jude Crosson Cancer Institute oncologists are aggressively pursuing new answers to metastatic prostate cancer, including research into an innovative immunotherapy called AMG 509.
-
Chasing a Cure for Macular Degeneration
When the SpaceX mission returns to earth in April, there will be 80 mice onboard who have spent a month living at the International Space Station. The rodents represent the first investigational ophth
-
New vaccine being studied for HPV-positive head and neck cancers
Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.
-
How promoting apoptosis in new study may help people with cancer
In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.
-
In the news: TIME highlights CORE’s long COVID research
A recent article in TIME magazine features research conducted by CORE and the Providence Research Network into the condition known as long COVID.
-
State-of-the-art A-fib treatment debuts at Providence Saint John’s Health Center
Four patients are among first in the nation to undergo groundbreaking pulsed field ablation procedure.
-
Providence Cancer Institute celebrates historic milestone to finish cancer
The FDA just approved a new immunotherapy for advanced melanoma. Dr. Walter Urba shares how Providence’s participation in the clinical study shows our standing as a global leader in immuno-oncology.
-
Dose-escalation studies aspire to fill gaps in cancer treatment options
Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.
-
FDA approves cellular therapy, offering hope to more people with cancer
The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).
-
Study of new heart-attack medication to begin in Anchorage
Anchorage Fire Department, Providence Alaska Medical Center and Alaska Cardiovascular Research Foundation to collaborate on study of a new medication for treating patients experiencing a heart attack.
-
Exploring Post-COVID syndrome research & treatments
Learn about the latest findings and treatments for post-COVID syndrome from Providence.
-
Providence study finds new workflow improves adherence to Infant Group B Strep Sepsis prevention guidelines
A recent Providence study revealed that integrating a dynamic EMR order set results in improved adherence to established guidelines associated with reduction in early onset GBS neonatal sepsis.
-
Celebrating Women in Science
In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.
-
CORE data analysis supports change in Portland's behavioral health landscape
A data analysis initiative supported by Providence CORE could significantly influence behavioral health policy and response strategies in Portland, Oregon, and statewide.
-
Revolutionary procedure brings new hope to liver cancer patients at Providence, Providence Swedish
Patients with liver cancer have a new treatment option, thanks to a revolutionary procedure being offered at Providence and Providence Swedish hospitals.
-
Navigating the path of genomic medicine: Insights from an early detection program
Research by Providence CORE offers insights to help healthcare organizations partner with patients to improve outcomes through genetic testing.
-
Studies address need for more treatment options in endometrial cancer and AML
New study evaluates immunotherapy in combination with other medications in people with endometrial cancer, and a phase I trial for people with AML assesses a non-engineered natural killer cell therapy
-
Providence researcher in the news: a promising treatment for kidney disease
A study led by Providence researcher Katherine Tuttle, MD, FACP, of Spokane, Washington is in the news thanks to findings around a promising new treatment for kidney disease.
- Loading More...